NCT05564169: Masitinib in Patients With Mild to Moderate Alzheimer's Disease |
|
|
| Not yet recruiting | 3 | 600 | Europe | Placebo, Placebo Oral Tablet, Masitinib (4.5), AB1010, Standard of care | AB Science | Alzheimer Disease | 12/26 | 12/26 | | |
| Recruiting | N/A | 14 | US | BrightGo cognitive training, Gamification for cognitive therapy, Standard of Care medication for early Alzheimer's Disease, Aricept 10 mg daily or Exelon 9.5 mg patch | Bright Cloud International Corp, National Institute on Aging (NIA), Rutgers, The State University of New Jersey | Alzheimer Disease, Healthy Aging | 12/22 | 02/23 | | |